Abstract: An ultrasonic mixing system having a treatment chamber in which at least two separate phases can be mixed to prepare an emulsion is disclosed. Specifically, at least one phase is a dispersed phase and one phase in a continuous phase. The treatment chamber has an elongate housing through which the phases flow longitudinally from a first inlet port and a second inlet port, respectively, to an outlet port thereof. An elongate ultrasonic waveguide assembly extends within the housing and is operable at a predetermined ultrasonic frequency to ultrasonically energize the phases within the housing. An elongate ultrasonic horn of the waveguide assembly is disposed at least in part intermediate the inlet and outlet ports, and has a plurality of discrete agitating members in contact with and extending transversely outward from the horn intermediate the inlet and outlet ports in longitudinally spaced relationship with each other.

Abstract: An ultrasonic mixing system having a treatment chamber in which antimicrobial agents, particularly, hydrophobic antimicrobial agents, can be mixed with one or more formulations is disclosed. Specifically, the treatment chamber has an elongate housing through which a formulation and antimicrobial agents flow longitudinally from a first inlet port and a second inlet port to an outlet port thereof. An elongate ultrasonic waveguide assembly extends within the housing and is operable at a predetermined ultrasonic frequency to ultrasonically energize the formulation and antimicrobial agents within the housing. An elongate ultrasonic horn of the waveguide assembly is disposed at least in part intermediate the inlet and outlet ports, and has a plurality of discrete agitating members in contact with and extending transversely outward from the horn intermediate the inlet and outlet ports in longitudinally spaced relationship with each other.

Abstract: An ultrasonic treatment system having a treatment chamber for treating a formulation to increase the shelf life thereof. In one embodiment, the shelf life is produced by degassing the formulation using the treatment chamber. Specifically, the treatment chamber has an elongate housing through which a formulation flows longitudinally from an inlet port to a first outlet port and a second outlet port thereof. An elongate ultrasonic waveguide assembly extends within the housing and is operable at a predetermined ultrasonic frequency to ultrasonically energize the formulation within the housing. An elongate ultrasonic horn of the waveguide assembly is disposed at least in part intermediate the inlet and outlet ports, and has a plurality of discrete agitating members in contact with and extending transversely outward from the horn intermediate the inlet and outlet ports in longitudinally spaced relationship with each other.

Abstract: An ultrasonic mixing system having a particulate dispensing system to dispense particulates into a treatment chamber and the treatment chamber in which particulates can be mixed with one or more formulations is disclosed. Specifically, the treatment chamber has an elongate housing through which a formulation and particulates flow longitudinally from an inlet port to an outlet port thereof. An elongate ultrasonic waveguide assembly extends within the housing and is operable at a predetermined ultrasonic frequency to ultrasonically energize the formulation and particulates within the housing. An elongate ultrasonic horn of the waveguide assembly is disposed at least in part intermediate the inlet and outlet ports, and has a plurality of discrete agitating members in contact with and extending transversely outward from the horn intermediate the inlet and outlet ports in longitudinally spaced relationship with each other.

Abstract: A mannequin suitable for testing absorbent articles has a surface having a coefficient of friction of 0.8 to 1.28 as measured by the Coefficient of Friction Test disclosed herein and a contact angle of 94 to 106 degrees as measured by the Contact Angle Test disclosed herein. In various embodiments, the mannequin may further have an indentation value of 3 to 7 kPa over the range of 0 to 4 mm of depth as measured by the Indentation Test disclosed herein. In various embodiments, the mannequin may further have a transmittance value of 50 to 90 percent, a haze value of 8 to 65 percent, and a clarity value of 10 to 80 percent as measured by the Optical Characteristics Test disclosed herein.

Abstract: The present disclosure generally relates to a formulation. More particularly, the formulation may be applied to skin and/or used in combination with a personal care product to improve absorbance and leakage control of the personal care product, and to promote a more positive feel and comfort through improved skin cleanliness and health.

Abstract: The present disclosure is generally directed to a composition comprising one or more elongated particles having a diameter of from about 5 nm to about 500 nm, a length that is greater than the diameter and an aspect ratio of greater than about 1. The aspect ratio affects the orientation of such elongated particles in relation to a surface on which the composition is applied.

Abstract: An adhesive composition comprises at least a binder polymer and a water-soluble plasticizer. The binder polymer may be present in a range of about 10% to about 60% by weight of the adhesive composition, and the plasticizer may be present in the range of about 5% to about 85% by weight of the adhesive composition, such as in the range of about 40% to about 80% by weight. In some aspects, the adhesive also comprises less than 10% by weight highly-volatile component, such as about 0% to about 5% by weight. The adhesive composition can be utilized in a variety of articles, including personal care articles, health/medical articles, and household/industrial articles.

Abstract: The present disclosure generally relates to absorbent articles, such as diapers, training pants, swim pants, incontinence articles, feminine care articles, and the like, that comprise a system for generating a fluid or odor barrier or interceptor. More specifically, the articles comprise a pre-use foam composition that when contacted with a triggering agent, expands to produce a foam barrier or interceptor structure that provides protection against leakage of the absorbent article.

Abstract: The present disclosure is directed to methods and compositions for clearing and cleaning enteral feeding tubes. More particularly, the composition is an ingestible gel composition that comprises enzymes for degrading buildup in enteral feeding tubes, carrageenan, and divalent metal ions or a source thereof. The carrageenan present in the composition stabilizes the enzymes at room temperatures, allowing for long-term storage of the composition. Upon injecting the gelled composition into the feeding tube, body heat from the patient melts the gel, and the enzymes are released to act on debris present in the feeding tube.

Abstract: The present invention is an aqueous, non-alcoholic liquid powder formulation. The aqueous, non-alcoholic liquid powder formulation comprises from about 14% to about 75% by weight of the formulation of water, from about 25% to about 60% by weight of the formulation of a powder, from about 0.05% to about 1% by weight of the formulation of a polymeric emulsifier, from about 0.5% to about 15% by weight of the formulation of a low molecular weight silicone wherein the low molecular weight silicone has an average molecular weight of about 10,000 or less, and from about 0.1% to about 10% by weight of the formulation of a high molecular weight silicone wherein the high molecular weight silicone has an average molecular weight of about 100,000 or greater. The aqueous, non-alcoholic liquid powder formulation may have an optical uniformity index of about 0.1 or less. The aqueous, non-alcoholic liquid powder formulation may have an extensive uniformity index of about 300 or greater.

Abstract: Wet and dry wipes comprising additives for removing allergens from surfaces are disclosed. The wipe substrate comprises an additive capable and binding the allergen onto the substrate such that the allergen can be removed from the surface. Various allergens including animal and pet dander can be removed from numerous surfaces utilizing the wipes of the present invention. In some embodiments of the invention, the allergenicity of the allergen is also reduced. Suitable additives for immobilization onto the wipe substrate include lectins, proteases, and enzyme inhibitors.

Abstract: A cleansing composition is disclosed that changes color during use. The cleansing composition contains a plurality of thermochromic dyes that cause a color change to occur at a threshold temperature and continue to cause a color change over a temperature range. The range of temperatures corresponds to approximately the amount of time sufficient to properly wash or scrub using the product.

Abstract: A method of providing a hygiene system includes providing a dispenser adapted to contain at least one product and deliver a dose of the product when activated; providing at least one applicator adapted to receive the dose of the product and transfer the dose of the product to a target surface; and providing a theme wherein the dispenser is adapted to simulate a first interactive component of the theme and the applicator is adapted to simulate a second interactive component of the theme.

Abstract: A dispenser includes (i) a reservoir containing a personal care composition, wherein the personal care composition is a moisturizer, sun-protective material, after-sun care material, skin conditioning agent, astringent material, skin cleanser, acne treatment, cosmetic remover, massage oil, or skin nutrient agent; (ii) at least one nozzle in fluid communication with the reservoir; and (iii) an on-off frequency generator in fluid communication between the reservoir and the nozzle, the frequency generator adapted to deliver a pulse rate frequency of 0.1 to 500 Hz.

Abstract: A cleansing composition is described. The cleansing composition generally contains an antimicrobial agent, a heating agent, and a thermochromic agent. During use, the heating agent heats the composition so that the antimicrobial agent becomes more effective. The thermochromic agent, on the other hand, changes the color of the composition as it is heated in order to indicate to a user that the composition is at a desired temperature. In an alternative embodiment, instead of containing a heating agent, a heating source can be used to heat the composition. The heating source can be, for instance, an electrical resistance heater.

Abstract: The present disclosure generally relates to compositions for reducing inflammation, and more particularly, to compositions comprising oleocanthal. The oleocanthal-containing compositions are particularly suitable for transdermal delivery. The compositions may also be used in combination with personal care products, such as wipes and absorbent articles, and may be incorporated into transdermal patches.

Abstract: Processes for preparing products comprising an oxygen-generating additive for reducing the amount of skin irritation and inflamation and odor are disclosed. Specifically, products such as training pants and diapers are disclosed which contain a carbohydrate-hydrogen peroxide crystalline powder which, when wetted, produces a stream of oxygen which can be used by various bacteria on and near the wearer's skin during metabolism resulting in a significant decrease in the amount of volatile organic compounds produced by the bacteria during metabolism.

Abstract: Absorbent products and wet wipes are disclosed that are useful in reducing the amount of ammonia produced by bacteria on or near the skin or in bodily fluids such as urine. The products described herein contain an osmoregulation protector which when introduced into a bacteria-containing environment interacts with the bacteria and reduces the amount of ammonia produced by the bacteria without significantly affecting the growth rate of the bacteria. The osmoregulation protectors described herein are particularly useful in combination with adult incontinence garments where the control of odors from bacterial by-products such as ammonia is highly desirable.

Abstract: A tampon adapted to deliver a therapeutic agent includes a body having a proximal end and a distal end. The body includes an absorbency zone adjacent the distal end, wherein the absorbency zone includes absorbent material; an application zone adjacent the proximal end and spaced apart from the distal end; and a therapeutic agent positioned substantially within the application zone. A method produces a device for delivering a therapeutic agent. The method includes manufacturing a tampon having a body with a distal end, a proximal end, an absorbency zone adjacent the distal end, and an application zone adjacent the proximal end; and locating a therapeutic agent substantially within the application zone.